• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多重静脉和肺动脉血栓形成作为接种新冠病毒(辉瑞/生物科技公司的BNT162b2)疫苗后自发可逆性肾病综合征的首发特征

Multiple Venous and Pulmonary Artery Thrombosis as the Presenting Features of Spontaneously Reversible Nephrotic Syndrome after Exposure to SARS-CoV-2 Virus (Pfizer/BioNTech BNT162b2) Vaccination.

作者信息

Thammathiwat Theerachai, Banjongjit Athiphat, Chumnumsiriwath Piyatida, Chompuk Laor, Sripariwuth Apichaya, Pongcharoen Sutatip, Kanjanabuch Talerngsak

机构信息

Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand.

Nephrology Unit, Department of Medicine, Vichaiyut Hospital, Bangkok 10400, Thailand.

出版信息

Vaccines (Basel). 2022 Nov 9;10(11):1888. doi: 10.3390/vaccines10111888.

DOI:10.3390/vaccines10111888
PMID:36366397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9697681/
Abstract

We report an unusual case of nephrotic syndrome and multiple venous thromboembolism (VTE) four days after BNT162b2 injection. The patient presented with a three-day history of foamy urine and one-day history of right leg swelling. The investigation showed 9.5 g of 24 hr urine protein, hypoalbuminemia (2.6 gm/dL), and hypercholesterolemia (320 mg/dL). The duplex ultrasonography revealed VTE of the right lower extremity veins (common femoral vein, saphenous vein, and popliteal vein). Computed tomography (CT) showed thrombosis of the infrarenal inferior vena cava (IVC) extending to both iliac veins and acute pulmonary embolism. Kidney biopsy was performed. The diagnosis of minimal change disease was made. The patient received anticoagulation without steroid or immunosuppressive medications. The nephrosis was spontaneously resolved in 20 days; thus, it strongly suggested the diagnosis of vaccine-induced minimal change nephropathy. Reports of kidney adverse events and clinical characteristics are further needed in the circumstances of worldwide SARS-CoV-2 vaccine usage.

摘要

我们报告了一例在注射BNT162b2疫苗四天后出现肾病综合征和多发性静脉血栓栓塞(VTE)的罕见病例。患者有三天泡沫尿病史和一天右腿肿胀病史。检查显示24小时尿蛋白9.5克、低白蛋白血症(2.6克/分升)和高胆固醇血症(320毫克/分升)。双功超声检查显示右下肢静脉(股总静脉、大隐静脉和腘静脉)发生VTE。计算机断层扫描(CT)显示肾下腔静脉(IVC)血栓形成并延伸至双侧髂静脉以及急性肺栓塞。进行了肾活检。诊断为微小病变病。患者接受了抗凝治疗,未使用类固醇或免疫抑制药物。肾病在20天内自行缓解;因此,强烈提示为疫苗诱导的微小病变肾病。在全球使用SARS-CoV-2疫苗的情况下,还需要进一步了解肾脏不良事件的报告和临床特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eab/9697681/7dbf76348a11/vaccines-10-01888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eab/9697681/a05ba681f1fa/vaccines-10-01888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eab/9697681/7dbf76348a11/vaccines-10-01888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eab/9697681/a05ba681f1fa/vaccines-10-01888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eab/9697681/7dbf76348a11/vaccines-10-01888-g002.jpg

相似文献

1
Multiple Venous and Pulmonary Artery Thrombosis as the Presenting Features of Spontaneously Reversible Nephrotic Syndrome after Exposure to SARS-CoV-2 Virus (Pfizer/BioNTech BNT162b2) Vaccination.多重静脉和肺动脉血栓形成作为接种新冠病毒(辉瑞/生物科技公司的BNT162b2)疫苗后自发可逆性肾病综合征的首发特征
Vaccines (Basel). 2022 Nov 9;10(11):1888. doi: 10.3390/vaccines10111888.
2
Multiple Venous and Pulmonary Artery Thrombosis as a Presenting Complaint of Nephrotic Syndrome-Case Report and Challenges in Management.多发性静脉和肺动脉血栓形成作为肾病综合征的首发表现-病例报告及治疗中的挑战。
Vasc Health Risk Manag. 2022 Jul 28;18:589-593. doi: 10.2147/VHRM.S371373. eCollection 2022.
3
Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?辉瑞-生物科技公司新冠疫苗接种后出现的小儿微小病变病和急性肾损伤:是因果关系还是偶然关联?
G Ital Nefrol. 2022 Dec 21;39(6):2022-vol6.
4
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.辉瑞-生物科技 COVID-19 疫苗接种后出现微小病变病。
Am J Kidney Dis. 2021 Jul;78(1):142-145. doi: 10.1053/j.ajkd.2021.03.010. Epub 2021 Apr 8.
5
A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.一位 59 岁女性,在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后 7 天出现广泛的深静脉血栓形成和肺血栓栓塞症。
Am J Case Rep. 2021 Jun 12;22:e932946. doi: 10.12659/AJCR.932946.
6
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.多国静脉血栓栓塞症注册研究中,接种 SARS-CoV-2 疫苗后 30 天内的静脉血栓栓塞症。
Viruses. 2022 Jan 18;14(2):178. doi: 10.3390/v14020178.
7
Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report.COVID-19 感染后肾病患者合并肠系膜静脉血栓形成:病例报告。
BMC Nephrol. 2021 Dec 29;22(1):420. doi: 10.1186/s12882-021-02643-0.
8
De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.一名活体肾供者接种辉瑞/生物科技公司的SARS-CoV-2疫苗后发生的新发微小病变病
Medicina (Kaunas). 2021 Dec 27;58(1):37. doi: 10.3390/medicina58010037.
9
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.健康女性在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后发生广泛脑静脉窦血栓形成(CVST),但无血栓性血小板减少综合征(TTS)。
Am J Case Rep. 2022 Feb 9;23:e934744. doi: 10.12659/AJCR.934744.
10
Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine.首剂辉瑞 - 生物科技公司新冠疫苗接种后发生的微小病变肾病:一例病例报告及与新冠疫苗相关的微小病变肾病综述
Can J Kidney Health Dis. 2021 Nov 15;8:20543581211058271. doi: 10.1177/20543581211058271. eCollection 2021.

引用本文的文献

1
Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.两例在接种新型冠状病毒疫苗后新诊断出的频繁复发肾病综合征青少年病例报告及文献综述
CEN Case Rep. 2025 Jun;14(3):461-467. doi: 10.1007/s13730-025-00967-6. Epub 2025 Feb 17.

本文引用的文献

1
New-Onset Acute Kidney Disease Post COVID-19 Vaccination.新冠疫苗接种后新发急性肾损伤
Vaccines (Basel). 2022 May 9;10(5):742. doi: 10.3390/vaccines10050742.
2
De novo Minimal Change Disease in an Adolescent after Pfizer-BioNTech COVID-19 Vaccination: A Case Report.辉瑞 - 生物科技公司新冠疫苗接种后一名青少年新发微小病变病:病例报告
Case Rep Nephrol Dial. 2022 Mar 21;12(1):44-49. doi: 10.1159/000521981. eCollection 2022 Jan-Apr.
3
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.mRNA 疫苗加强剂对卡塔尔奥密克戎感染的保护效果。
N Engl J Med. 2022 May 12;386(19):1804-1816. doi: 10.1056/NEJMoa2200797. Epub 2022 Mar 9.
4
Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.辉瑞-生物科技 COVID-19 疫苗接种后出现微小病变病的肾病综合征:两例报告。
BMJ Case Rep. 2022 Mar 4;15(3):e244638. doi: 10.1136/bcr-2021-244638.
5
Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination.接种SARS-CoV-2 BNT162b2疫苗后出现的微小病变性肾病和急性间质性肾炎。
Pediatr Nephrol. 2022 Jun;37(6):1419-1421. doi: 10.1007/s00467-022-05470-z. Epub 2022 Feb 7.
6
De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.一名活体肾供者接种辉瑞/生物科技公司的SARS-CoV-2疫苗后发生的新发微小病变病
Medicina (Kaunas). 2021 Dec 27;58(1):37. doi: 10.3390/medicina58010037.
7
Molecular Mechanisms of Proteinuria in Minimal Change Disease.微小病变性肾病蛋白尿的分子机制
Front Med (Lausanne). 2021 Dec 23;8:761600. doi: 10.3389/fmed.2021.761600. eCollection 2021.
8
Report of two cases of minimal change disease following vaccination for COVID -19.两例接种新冠疫苗后发生微小病变病的病例报告。
Nephrology (Carlton). 2022 Jan;27(1):111-112. doi: 10.1111/nep.13995. Epub 2021 Nov 15.
9
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
10
Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.辉瑞-生物科技公司新冠疫苗接种后出现的微小病变性肾病和急性肾损伤。
Kidney Int. 2021 Aug;100(2):461-463. doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15.